Zobrazeno 1 - 8
of 8
pro vyhledávání: '"P W, Hruz"'
Autor:
Shawna L. McMillin, Parker L. Evans, William M. Taylor, Luke A. Weyrauch, Tyler J. Sermersheim, Steven S. Welc, Monique R. Heitmeier, Richard C. Hresko, Paul W. Hruz, Francoise Koumanov, Geoffrey D. Holman, E. Dale Abel, Carol A. Witczak
Publikováno v:
Biomolecules, Vol 12, Iss 12, p 1734 (2022)
Glucose transporter 1 (GLUT1) is believed to solely mediate basal (insulin-independent) glucose uptake in skeletal muscle; yet recent work has demonstrated that mechanical overload, a model of resistance exercise training, increases muscle GLUT1 leve
Externí odkaz:
https://doaj.org/article/147a73ac6c2d4bab8a2344c5e3fe0de0
Autor:
Monique R. Heitmeier, Maria A. Payne, Carla Weinheimer, Attila Kovacs, Richard C. Hresko, Patrick Y. Jay, Paul W. Hruz
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-10 (2018)
Abstract GLUT transgenic and knockout mice have provided valuable insight into the role of facilitative glucose transporters (GLUTs) in cardiovascular and metabolic disease, but compensatory physiological changes can hinder interpretation of these mo
Externí odkaz:
https://doaj.org/article/eeb94a2a3685407890ba31775830ba3a
Autor:
Rachel L. Edwards, Robert C. Brothers, Xu Wang, Maxim I. Maron, Peter D. Ziniel, Patricia S. Tsang, Thomas E. Kraft, Paul W. Hruz, Kim C. Williamson, Cynthia S. Dowd, Audrey R. Odom John
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-11 (2017)
Abstract The emergence of Plasmodium falciparum resistant to frontline therapeutics has prompted efforts to identify and validate agents with novel mechanisms of action. MEPicides represent a new class of antimalarials that inhibit enzymes of the met
Externí odkaz:
https://doaj.org/article/539d6d0aabfc46c68f5a489b64e29fac
Autor:
Monique R Heitmeier, Richard C Hresko, Rachel L Edwards, Michael J Prinsen, Ma Xenia G Ilagan, Audrey R Odom John, Paul W Hruz
Publikováno v:
PLoS ONE, Vol 14, Iss 5, p e0216457 (2019)
Although the Plasmodium falciparum hexose transporter PfHT has emerged as a promising target for anti-malarial therapy, previously identified small-molecule inhibitors have lacked promising drug-like structural features necessary for development as c
Externí odkaz:
https://doaj.org/article/5b482186f44d47e980b0f7cc11450eff
Autor:
Arpita Kalla Vyas, Kai-Chien Yang, Dennis Woo, Anatoly Tzekov, Attila Kovacs, Patrick Y Jay, Paul W Hruz
Publikováno v:
PLoS ONE, Vol 6, Iss 2, p e17178 (2011)
There is growing awareness of secondary insulin resistance and alterations in myocardial glucose utilization in congestive heart failure. Whether therapies that directly target these changes would be beneficial is unclear. We previously demonstrated
Externí odkaz:
https://doaj.org/article/78ccf4e41e83411190ae8c474fd1cb3f
Autor:
Richard C Hresko, Paul W Hruz
Publikováno v:
PLoS ONE, Vol 6, Iss 9, p e25237 (2011)
The clinical use of several first generation HIV protease inhibitors (PIs) is associated with the development of insulin resistance. Indinavir has been shown to act as a potent reversible noncompetitive inhibitor of zero-trans glucose influx via dire
Externí odkaz:
https://doaj.org/article/bd4b1ea7324244afb0ae5d31247e75d3
Publikováno v:
The Journal of biological chemistry. 269(27)
cDNA encoding the mature form of human hydroxy-methylglutaryl-CoA (HMG-CoA) lyase, a mitochondrial matrix protein, has been used to prepare expression plasmids appropriate for production of this protein in Escherichia coli. Using a T7 RNA polymerase-
Autor:
G A, Mitchell, M F, Robert, P W, Hruz, S, Wang, G, Fontaine, C E, Behnke, L M, Mende-Mueller, K, Schappert, C, Lee, K M, Gibson, H M, Miziorko
Publikováno v:
The Journal of biological chemistry. 268(6)
3-Hydroxy-3-methylglutaryl coenzyme A lyase (HL) catalyzes the final step of ketogenesis, an important pathway of mammalian energy metabolism. HL deficiency is an autosomal recessive inborn error in man leading to episodes of hypoglycemia and coma. U